Vogt A - Search Results

1

A High-Throughput Assay for DNA Replication Inhibitors Based upon Multivariate Analysis of Yeast Growth Kinetics.

Ngo M, Wechter N, Tsai E, Shun TY, Gough A, Schurdak ME, Schwacha A, Vogt A. Ngo M, et al. Among authors: vogt a. SLAS Discov. 2019 Jul;24(6):669-681. doi: 10.1177/2472555219829740. Epub 2019 Feb 25. SLAS Discov. 2019. PMID: 30802412 Free PMC article.

2

A high-content screening assay in transgenic zebrafish identifies two novel activators of fgf signaling.

Saydmohammed M, Vollmer LL, Onuoha EO, Vogt A, Tsang M. Saydmohammed M, et al. Among authors: vogt a. Birth Defects Res C Embryo Today. 2011 Sep;93(3):281-7. doi: 10.1002/bdrc.20216. Birth Defects Res C Embryo Today. 2011. PMID: 21932436 Free PMC article. Review.

3

Evolution of Experimental Models of the Liver to Predict Human Drug Hepatotoxicity and Efficacy.

Vernetti LA, Vogt A, Gough A, Taylor DL. Vernetti LA, et al. Among authors: vogt a. Clin Liver Dis. 2017 Feb;21(1):197-214. doi: 10.1016/j.cld.2016.08.013. Clin Liver Dis. 2017. PMID: 27842772 Free PMC article. Review.

4

Exploiting Analysis of Heterogeneity to Increase the Information Content Extracted from Fluorescence Micrographs of Transgenic Zebrafish Embryos.

Shun T, Gough AH, Sanker S, Hukriede NA, Vogt A. Shun T, et al. Among authors: vogt a. Assay Drug Dev Technol. 2017 Aug/Sep;15(6):257-266. doi: 10.1089/adt.2017.793. Epub 2017 Aug 11. Assay Drug Dev Technol. 2017. PMID: 28800244 Free PMC article.

5

Development and Optimization of a High-Content Analysis Platform to Identify Suppressors of Lamin B1 Overexpression as a Therapeutic Strategy for Autosomal Dominant Leukodystrophy.

Nmezi B, Vollmer LL, Shun TY, Gough A, Rolyan H, Liu F, Jia Y, Padiath QS, Vogt A. Nmezi B, et al. Among authors: vogt a. SLAS Discov. 2020 Sep;25(8):939-949. doi: 10.1177/2472555220915821. Epub 2020 Apr 30. SLAS Discov. 2020. PMID: 32349647 Free PMC article.

6

A High-Content Screening Assay for Small Molecules That Stabilize Mutant Triose Phosphate Isomerase (TPI) as Treatments for TPI Deficiency.

Vogt A, Eicher SL, Myers TD, Hrizo SL, Vollmer LL, Meyer EM, Palladino MJ. Vogt A, et al. SLAS Discov. 2021 Sep;26(8):1029-1039. doi: 10.1177/24725552211018198. Epub 2021 Jun 24. SLAS Discov. 2021. PMID: 34167376 Free PMC article.

7

A systems-level study reveals host-targeted repurposable drugs against SARS-CoV-2 infection.

Chen F, Shi Q, Pei F, Vogt A, Porritt RA, Garcia G Jr, Gomez AC, Cheng MH, Schurdak ME, Liu B, Chan SY, Arumugaswami V, Stern AM, Taylor DL, Arditi M, Bahar I. Chen F, et al. Among authors: vogt a. Mol Syst Biol. 2021 Aug;17(8):e10239. doi: 10.15252/msb.202110239. Mol Syst Biol. 2021. PMID: 34339582 Free PMC article.

8

Validation of a high throughput screening assay to identify small molecules that target the eukaryotic replicative helicase.

Sanders J, Castiglione M, Shun T, Vollmer LL, Schurdak ME, Vogt A, Schwacha A. Sanders J, et al. Among authors: vogt a. SLAS Discov. 2022 Jun;27(4):229-241. doi: 10.1016/j.slasd.2021.12.006. Epub 2022 Jan 8. SLAS Discov. 2022. PMID: 35058181 Free PMC article.

9

Implementation of high-content assay for inhibitors of mitogen-activated protein kinase phosphatases.

Vogt A, Lazo JS. Vogt A, et al. Methods. 2007 Jul;42(3):268-77. doi: 10.1016/j.ymeth.2007.02.006. Methods. 2007. PMID: 17532514 Free PMC article.

10

Cell-active dual specificity phosphatase inhibitors identified by high-content screening.

Vogt A, Cooley KA, Brisson M, Tarpley MG, Wipf P, Lazo JS. Vogt A, et al. Drug Discov Today. 2005 Autumn;Suppl:3-12. Drug Discov Today. 2005. PMID: 23570161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,055 results

Search Page

Filters